Elanix Biotechnologies AG

DUSE:ELN Stock Report

Market Cap: €428.3k

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Elanix Biotechnologies Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Lee-Ann Laurent-Applegate

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenureno data
Board average tenure3.5yrs

Recent management updates

No updates

Recent updates

No updates


CEO

Lee-Ann Laurent-Applegate

no data

Tenure

Prof. Lee-Ann Laurent-Applegate serves as Chief Executive Officer of Elanix Biotechnologies AG.


Board Members

NamePositionTenureCompensationOwnership
Anja Silling
Chairman of Supervisory Board4.3yrsno datano data
Marco Christen
Vice Chairman of Supervisory Board3.5yrsno data21.4%
€ 91.6k
Yves Bonnard
Member of Supervisory Board3.5yrsno datano data

3.5yrs

Average Tenure

Experienced Board: ELN's board of directors are considered experienced (3.5 years average tenure).